The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
Clinical trial NCT04746092 · UNKNOWN
Trial details
- NCT number
- NCT04746092
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-06
- Primary completion
- 2022-05-24
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.